Immunohistochemical analysis of metastasising hepatocellular carcinomas in dogs R., Bandoch P., Lewandowska K., Madej J.A., Kandefer-Gola M., Janus I., Nowak M. (2016): Immunohistochemical analysis of metastasising hepatocellular carcinomas in dogs. Veterinarni Medicina, 61: 546-552.
download PDF

In this study, the immunohistochemical features of primary hepatocellular carcinomas and their metastases in visceral organs, including the lungs, spleen and kidneys were examined using antibodies against carcino-embryonic antigen (CEA) cytokeratin (CK) 7 and 20, CD4, CD8, minichromosome maintenance protein 3 (MCM3), vimentin, and alpha 1 foetoprotein (AFP). In addition, Mallory’s connective tissue stain, van Gieson’s stain and Gomori methenamine silver stain were used. The study was performed on liver samples collected post mortem from five mixed-breed dogs aged 9–12 years. The tumours were classified according to the World Health Organization Classification of Tumours. Strong expression of MCM3 and AFP was found in the hepatic cancer cells and in the metastases to the lungs, spleen and kidneys. The primary tumours and metastatic foci did not react positively with the anti-CD4, anti-CD8, CEA, CK7 and CK20 antibodies. The connective tissue in the primary tumour and the metastases showed a positive reaction to vimentin. Canine hepatocellular carcinomas that metastasise are highly-malignant well-differentiated tumours that produce AFP and trace amounts of both carcinoembryonic antigen and cytokeratin. Therefore, the metastasis resembles the primary tumour and has a common phenotype and genotype with the primary tumour.

Center SA, Slater MR, Manwarren T, Prymak K (1992): Diagnostic efficacy of serum alkaline phospathase and γ-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980–1990). Journal of the American Veterinary Medical Association 201, 1258–1265.
Clayton Erica Fan, Furth Emma Elizabeth, Ziober Amy, Xu Theodore, Yao Yuan, Hwang Pil Gyu, Bing Zhanyong (2012): A case of primary clear cell hepatocellular carcinoma in a non-cirrhotic liver: an immunohistochemical and ultrastructural study. Rare Tumors, 4, -
Martín De Las Mulas J, Gómez-Villamandos J.C, Pérez J, Mozos E, Estrada M, Méndez A (1995): Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin. Research in Veterinary Science, 59, 124-127
Dellagi K, Vainchenker W, Vinci G, Paulin D, Brouet J, Cembo J (1983): Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells. The EMBO Journal 2, 1509–1514.
EASL-EORTC – European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012): EASL-EORTC Clinical practice guidelines: Management of hepatocellular carcinoma. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. Journal of Hepatology 56, 908–943.
Endl Elmar, Kausch Ingo, Baack Martina, Knippers Rolf, Gerdes Johannes, Scholzen Thomas (2001): The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells. The Journal of Pathology, 195, 457-462
Hamilton SR, Aaltonen LA (2000): 8 Tumours of the liver and intrahepatic bile ducts. In: Kleihues P, Sobin LH (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. IARC Press, Lyon. 157–199.
Handra-Luca A, Hong S-M, Walter K, Wolfgang C, Hruban R, Goggins M (): Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas. British Journal of Cancer, 104, 1296-1302
Jia Shu-Qin, Ren Jian-Jun, Dong Pei-De, Meng Xing-Kai (2013): Probing the Hepatic Progenitor Cell in Human Hepatocellular Carcinoma. Gastroenterology Research and Practice, 2013, 1-5
Kapatkin AS, Mullen HS, Matthiesen DT, Patnaik AK (1992): Leiomyosarcoma in dogs: 44 cases (1983–1988). Journal of the American Veterinary Medical Association 201, 1077–1079.
Kitao S., Yamada T., Ishikawa T., Madarame H., Furuichi M., Neo S., Tsuchiya R., Kobayashi K. (2006): Alpha-Fetoprotein in Serum and Tumor Tissues in Dogs with Hepatocellular Carcinoma. Journal of Veterinary Diagnostic Investigation, 18, 291-295
Krus S, Skrzypek-Fakhoury E (1996): 12 Morphological background of insufficiency of liver and biliary system (in Polish). In: Krus S, Skrzypek-Fakhoury E (eds): Clinical Pathomorphology (in Polish). 3rd edn. Wydawnictwo Lekarskie PZWL, Warszawa. 465–531.
Lahat Guy, Zhu Quan-Sheng, Huang Kai-Lieh, Wang Suizhao, Bolshakov Svetlana, Liu Jeffery, Torres Keila, Langley Robert R., Lazar Alexander J., Hung Mien Chie, Lev Dina, Bauer Joseph Alan (2010): Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies. PLoS ONE, 5, e10105-
LEE JI-WOON, KIM MAN-WOO, CHOI NAM-KYU, CHO IN-JU, HONG RAN (2014): Double primary hepatic cancer (sarcomatoid carcinoma and hepatocellular carcinoma): A case report. Molecular and Clinical Oncology, 2, 949-952
Leibman NF, Larson VS, Ogilvie GK (2003): 11 Oncologic diseases of the digestive system. In: Tams TR (ed.): Handbook of Small Animal Gastroenterology. Saunders, St Louis. 370–415.
Leong ASY, Cooper K, Leong FJWM (1999): Manual of diagnostic antibodies for immunohistology. Greenwich Medical Media Ltd., London. 385 pp.
Liptak Julius M., Dernell William S., Monnet Eric, Powers Barbara E., Bachand Annette M., Kenney Juanita G., Withrow Stephen J. (2004): Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002). Journal of the American Veterinary Medical Association, 225, 1225-1230
Maliszewski D, Jastrzebski T, Drucis K, Kopacz A (2008): Prognostic factors in colon cancer – what can we add to the standards? Wspolczesna Onkologia 5, 212–216.
Masserdotti Carlo, Drigo Michele (2012): Retrospective study of cytologic features of well-differentiated hepatocellular carcinoma in dogs. Veterinary Clinical Pathology, 41, 382-390
Mizejewski G. J. (1997):  -Fetoprotein as a Biologic Response Modifier: Relevance to Domain and Subdomain Structure. Experimental Biology and Medicine, 215, 333-362
Monlux AW, Anderson WA, Davis CL (1956): A survey of tumors occurring in cattle, sheep and swine. American Journal of Veterinary Research 17, 646–677.
Mulligan RM (1949): Primary liver-cell carcinoma, hepatoma in the dog. Cancer Research 9, 76–81.
Mulligan RM, Mulligan I (eds) (1949): Neoplasms of the dog. Williams and Wilkins, Baltimore. 111–114.
Musahl C (1998): Stability of the Replicative Mcm3 Protein in Proliferating and Differentiating Human Cells. Experimental Cell Research, 241, 260-264
Nakajima S. (2004): N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Clinical Cancer Research, 10, 4125-4133
Nowak M, Madej JA (2006): Prevalence of neoplasms in domestic animals in Lower Silesia between 2000 and 2004 (in Polish). Medycyna Weterynaryjna 62, 900–904.
Nowak M, Madej JA, Dziegiel P (2008): Correlation between the expression of Mcm-3 protein and Ki-67 antigen in mammary adenocarcinomas of dogs. Bulletin of the Veterinary Institute in Pulawy 52, 701–705.
Nowak M, Madej JA, Ciaputa R, Poradowski D (2010): Manifestation of tumors in domestic animals in Lower Silesia in 2005–2008. Bulletin of the Veterinary Institute in Pulawy 54, 229–236.
Nyland Thomas G., Koblik Philip D., Tellyer Sharon E. (1999): ULTRASONOGRAPHIC EVALUATION OF BILIARY CYSTADENOMAS IN CATS. Veterinary Radiology <html_ent glyph="@amp;" ascii="&amp;"/> Ultrasound, 40, 300-306
Patnaik A. K., Hurvitz A. I., Lieberman P. H. (1980): Canine Hepatic Neoplasms: A Clinicopathologic Study. Veterinary Pathology, 17, 553-564
Patnaik A. K., Hurvitz A. I., Lieberman P. H., Johnson G. F. (2016): Canine Hepatocellular Carcinoma. Veterinary Pathology, 18, 427-438
Popp JA (1990): Tumors of the liver, gall bladder, and pancreas. In: Moulton JE (ed.): Tumors in Domestic Animals. University of California Press, Berkley. 436–445.
Post G, Patnaik AK (1992): Nonhematopoietic hepatic neoplasms in cats: 21 cases (1983–1988). Journal of the American Veterinary Medical Association 201, 1080–1082.
Ramaiah SK, Alleman AR (2002): Cytologic evaluation of the liver: aspiration findings and limitations. Compendium on Continuing Education for the Practising Veterinarian 24, 798–810.
Remmele W, Stegner HE (1987): Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologie 8, 138–140.
Schlageter Manuel, Terracciano Luigi Maria, D’Angelo Salvatore, Sorrentino Paolo (2014): Histopathology of hepatocellular carcinoma. World Journal of Gastroenterology, 20, 15955-
Song E, Reef E, Disler LJ, Kew MC (1982): Carcino-embryonic antigen in hepatocellular carcinoma. Report of a patient with very high serum concentrations. South African Medical Journal 62, 336–338.
Teshima T, Matsumoto H, Shigihara K, Sawada H, Michishita M, Takahashi K, Koyama H (2013): Hepatocellular carcinoma in a young dog. The Canadian Veterinary Journal 54, 845–848.
van Sprundel Renee G.H.M., van den Ingh Ted S.G.A.M., Guscetti Franco, Kershaw Olivia, Kanemoto Hideyuki, van Gils Henrika M., Rothuizen Jan, Roskams Tania, Spee Bart (2013): Classification of primary hepatic tumours in the dog. The Veterinary Journal, 197, 596-606
van Sprundel Renee G.H.M., van den Ingh Ted S.G.A.M., Guscetti Franco, Kershaw Olivia, van Wolferen Monique E., Rothuizen Jan, Spee Bart (2014): Classification of primary hepatic tumours in the cat. The Veterinary Journal, , -
Withrow SJ (2001): Cancer of the gastrointestinal tract. Small Animal Clinical Oncology 3, 305–353.
download PDF

© 2022 Czech Academy of Agricultural Sciences | Prohlášení o přístupnosti